Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community ...

Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

Integrative oncology combines standard cancer treatments with complementary therapies to manage symptoms and improve ...

“These findings by our University of Hawai‘i Cancer Center research team show that drug resistance is not necessarily the end ...

Moffitt at Speros Outpatient Center is now scheduling appointments ahead of its January 2026 opening, bringing exceptional ...

The largest international gathering of breast cancer researchers returns to San Antonio and continues to lead as the hub for scientific breakthroughs. Mays Cancer Center at UT Health San Antonio, in ...

Physician, known for his patient work at Sharp HealthCare, also helped found key cancer research center. He died Dec. 1 at ...

While the discontinued trial yielded early and sustained anti-tumor responses, next generation G12C inhibitors are establishing a new benchmark with higher response rates, Verastem CMO said. ・Verastem ...

The University of Kansas Cancer Center may get additional federal funding, which could help it hire researchers.